Fri 11/26/2021 06:12 AM
Share this article:
GenesisCare leveraged loan coverage.

GenesisCare’s gradual recovery was derailed by a surge in new Delta cases during its first quarter ended Sept. 30, hitting earnings and stoking cashburn. Growing demand and a backlog for oncology and cardiology services should help the Australia-headquartered global cancer treatment provider recover when the pandemic eases, but with leverage approaching double-digits and liquidity falling fast, management is seeking support from shareholders, sources
Share this article:
This article is an example of the content you may receive if you subscribe to a product of Reorg Research, Inc. or one of its affiliates (collectively, “Reorg”). The information contained herein should not be construed as legal, investment, accounting or other professional services advice on any subject. Reorg, its affiliates, officers, directors, partners and employees expressly disclaim all liability in respect to actions taken or not taken based on any or all the contents of this publication. Copyright © 2022 Reorg Research, Inc. All rights reserved.
Thank you for signing up
for Reorg on the Record!